Lantheus saw the highest growth of 1.99% in patent filings in April and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and grants by 0.24%. GlobalData’s DataBook provides a comprehensive analysis of Lantheus’s patent filings and grants. Buy the databook here.
Lantheus has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 67% filings and 50% grants. The United States(US), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where Lantheus is filings its patents. Among the top granted patent authorities, Lantheus has 50% of its grants in United States(US) and 50% in China(CN).
Roche and Johnson & Johnson could be the strongest competitors for Lantheus
Patents related to healthtech and computer vision lead Lantheus's portfolio
Lantheus has the highest number of patents in healthtech followed by, computer vision and electronic medical record (emr) systems. For healthtech, nearly 26% of patents were filed and no patents were granted in Q2 2024.
Diagnostic imaging related patents lead Lantheus portfolio followed by healthcare it, and image management
Lantheus has highest number of patents in diagnostic imaging followed by healthcare it, image management, medical imaging information systems, and gamma camera. For diagnostic imaging, nearly 19% of patents were filed and 67% of patents were granted in Q2 2024.
For comprehensive analysis of Lantheus's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.